ROYAL BANK OF CANADA - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$94,122,000
+45.5%
4,049,986
-0.4%
0.04%
+48.3%
Q1 2018$64,709,000
-19.1%
4,064,576
+5.6%
0.03%
-17.1%
Q4 2017$79,973,000
+132.8%
3,848,622
+60.6%
0.04%
+118.8%
Q3 2017$34,350,000
-12.8%
2,397,002
+5.3%
0.02%
-20.0%
Q2 2017$39,380,000
+36.4%
2,276,364
-13.0%
0.02%
+25.0%
Q1 2017$28,861,000
-40.5%
2,616,584
-21.7%
0.02%
-38.5%
Q4 2016$48,493,000
-38.7%
3,339,752
+3.7%
0.03%
-42.2%
Q3 2016$79,095,000
+59.7%
3,221,790
+31.0%
0.04%
+55.2%
Q2 2016$49,536,000
-55.9%
2,459,638
-42.4%
0.03%
-58.0%
Q1 2016$112,321,000
-74.5%
4,270,709
-1.4%
0.07%
-76.2%
Q4 2015$440,130,000
-41.5%
4,329,849
+2.7%
0.29%
-48.6%
Q3 2015$752,068,000
-14.4%
4,216,103
+6.6%
0.56%
-7.1%
Q2 2015$878,802,000
+6.0%
3,955,898
-5.2%
0.61%
+5.0%
Q1 2015$828,980,000
+49.3%
4,173,700
+7.6%
0.58%
+61.0%
Q4 2014$555,207,000
+18.5%
3,879,589
+8.6%
0.36%
+12.2%
Q3 2014$468,550,000
-2.4%
3,571,257
-6.2%
0.32%
-1.8%
Q2 2014$479,926,000
-7.7%
3,805,321
-3.5%
0.33%
-14.4%
Q1 2014$519,798,000
+12.8%
3,942,935
+0.5%
0.38%
+16.5%
Q4 2013$460,685,000
+11.0%
3,924,073
-1.3%
0.33%
+2.8%
Q3 2013$414,866,000
+22.7%
3,976,486
+1.2%
0.32%
+11.2%
Q2 2013$338,167,0003,928,5200.29%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders